Register entry

AGC Biologics, Inc.

Data as of · How to read this entry

Registered sites
7
Active NDC listings
12
Labeller names
5
Live patents
0
Countries
5
Base
United States
Authorisation

Registered operations

Analytical testing6Active ingredient (API) manufacture6Finished drug manufacture2
Sites

Registered establishments

7
EstablishmentAddressRegistered forFEI / DUNS
AGC Biologics GmbHCzernyring 22, Heidelberg, Baden-Wuerttemberg 69115, Germany (DEU)Analytical testing3003323027499129666
AGC Biologics A/SVandtaarnsvej 83B, Soeborg, Copenhagen 2860, Denmark (DNK)Analytical testing, Active ingredient (API) manufacture3004708748307169677
AGC Biologics SPAVIA ANTONIO MEUCCI 3, Bresso, Milan 20091, Italy (ITA)Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture3020270660428486752
AGC Inc.10, Goikaigan, Ichihara, Chiba 290-8566, Japan (JPN)Active ingredient (API) manufacture3003282601695073924
AGC Biologics, Inc.21511 23rd Dr SE, Bothell, Washington (WA) 98021, United States (USA)Analytical testing, Active ingredient (API) manufacture3000209996824771724
AGC Biologics Inc.5550 Airport Blvd, Boulder, Colorado (CO) 80301-2340, United States (USA)Analytical testing, Active ingredient (API) manufacture3018698628117594220
AGC Biologics Inc.4000 Nelson Rd, Longmont, Colorado (CO) 80503-9004, United States (USA)Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture3020775398118317062
Catalogue

Drug listings by form and route

12

12 active NDC listings: 10 drug for further processing, 2 bulk ingredient. By marketing category: DRUG FOR FURTHER PROCESSING 10, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 2.

Dosage formNDCs
solution11
liquid1
RouteNDCs
Labeller name on the listingNDCs
agc biologics, inc.5
agc biologics a/s4
agc biologics inc.1
agc inc.1
agc, inc.1
Catalogue

Marketed products

12
BrandGeneric nameForm / routeNDC
-AFLIBERCEPTsolution83277-004DRUG FOR FURTHER PROCESSING
-ASPARAGINASE ERWINIA CHRYSANTHEMIsolution82507-001DRUG FOR FURTHER PROCESSING
-AXATILIMABsolution83277-005DRUG FOR FURTHER PROCESSING
-COAGULATION FACTOR IX RECOMBINANT HUMANsolution83277-001DRUG FOR FURTHER PROCESSING
-ETUVETIDIGENE AUTOTEMCELsolution83277-100DRUG FOR FURTHER PROCESSING
-NOGAPENDEKIN ALFAsolution83277-003DRUG FOR FURTHER PROCESSING
-Perfluorhexlyoctaneliquid75872-0002BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-TEBENTAFUSPsolution82507-003DRUG FOR FURTHER PROCESSING
-TEPLIZUMABsolution83277-002DRUG FOR FURTHER PROCESSING
-TEPROTUMUMABsolution82507-002DRUG FOR FURTHER PROCESSING
-Tafluprostsolution75872-0001BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Ustekinumabsolution82507-004DRUG FOR FURTHER PROCESSING
Neighbours

Registered in the same town

10
Compare

Comparable companies in United States

Enquiry

Common questions

Is AGC Biologics, Inc. FDA approved?
AGC Biologics, Inc. holds 7 FDA-registered establishments across 5 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are AGC Biologics, Inc.'s drugs manufactured?
At registered sites in Germany, Denmark, Italy, Japan, the United States. The FDA register lists Heidelberg; Soeborg; Bresso; Ichihara; Bothell, WA; Boulder, CO, and 1 more. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture.
What drugs does AGC Biologics, Inc. make?
12 products are listed under AGC Biologics, Inc. in the openFDA NDC Directory, most often as solution; liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.